Influenza virus contains three integral membrane proteins: haemagglutinin, neuraminidase, and matrix protein (M1 and M2). Among them, M2 protein functions as an ion channel, important for virus uncoating in endosomes of virus-infected cells and essential for virus replication. In an effort to explore potential new functions of M2 in the virus life cycle, we used yeast two-hybrid system to search for M2-associated cellular proteins. One of the positive clones was identified as human Hsp40/Hdj1, a DnaJ/Hsp40 family protein. Here, we report that both BM2 (M2 of influenza B virus) and A/M2 (M2 of influenza A virus) interacted with Hsp40 in vitro and in vivo. 
INTRODUCTION
Influenza virus is an important human and zoonotic pathogen, prevalent throughout the world for centuries. The two predominant types of influenza viruses that infect humans are influenza A and B viruses. Both influenza A and influenza B viruses in the family Orthomyxoviridae have negativestranded RNA genomes consisting of eight RNA segments. RNA segments 1-3 encode the three polymerase proteins, PB1, PB2, and PA; RNA segment 4 encodes haemagglutinin (HA); RNA segment 5 encodes nucleoprotein (NP); RNA segment 6 encodes neuraminidase (NA); RNA segment 7 encodes two matrix proteins: M1 and M2; RNA segment 8 encodes two non-structural proteins NS1 and NS2 (nuclear export protein/NEP).
The M2 protein of influenza A virus (A/M2) is translated from a spliced mRNA, containing 97 amino acid residues in length (Lamb et al., 1981) . A/M2 has an ion channel activity to permit protons to enter virions and cause RNP-M1 dissociation during uncoating of virions in endosomes (Sugrue and Hay, 1991; Pinto et al., 1992; Takeda et al., 2002) . A/M2 channel activity was required for the activation of inflammasomes by influenza and was sufficient to activate inflammasomes in primed macrophages and dendritic cells (Ichinohe et al., 2010) . A/M2 also functions to equilibrate the pH gradient between the lumen of the trans-Golgi network (TGN) and the cytoplasm to prevent HA from adopting a low-pH-induced conformation in the Golgi apparatus (Ciampor et al., 1992; Shimbo et al., 1996) . Cytoplasmic tail of the A/M2 plays a vital role in infectious virus production by coordinating the efficient packaging of genome segments into influenza virus particles (McCown and Pekosz, 2006) . Unlike the A/M2 protein, the M2 protein of influenza B virus (BM2) is translated from a bicistronic mRNA derived from RNA segment 7 (Briedis et al., 1982; Horvath et al., 1990) , containing 109 amino acid residues, with a small N-terminal ectodomain (1-7 aa), a single transmembrane domain (8-27 aa) and a Cterminal cytoplasmic tail (28-109 aa) (Pinto and Lamb, 2006) . In addition to its obvious ion channel activity (Mould et al., 2003) , BM2 protein has recently been found to be essential for influenza B virus replication as shown by the experimental data of reverse genetics technology (Hatta et al., 2004) .
There is increasing evidence suggesting that the proteinprotein interactions between virus and host play an important role in the life cycle and pathogenicity of viruses (Liu et al., 2009) . But so far no interacting host partners of influenza virus M2 protein have been identified, except for our recent findings of the host ATPase β1 unit (Mi et al., 2010) . In this study, a yeast two-hybrid system was used to screen a human kidney cDNA library so as to identify host proteins that interact with BM2. One clone encoding heat shock protein Hsp40 (Hdj1/ DnajB1/DjB1), a DnaJ/Hsp40 family protein, was identified. We further presented our experimental data to show that both A/M2 and BM2 interacted with Hsp40/Hdj1 in vitro and in vivo. It has been reported that Hsp40 associates with P58 IPK , a cellular inhibitor of PKR, an interferon-induced doublestranded RNA activated serine-threonine kinase (Melville et al., 1997) , which is a novel "CIHD" member of the host innate defense response against pathogenic virus. Infection of P58 IPK knockout mice with influenza virus resulted in increased lung pathology, immune cell apoptosis, PKR activation, and mortality (Goodman et al., 2009) . It has been also previously reported that Influenza virus infection promotes the disruption of the Hsp40-P58 IPK complex and the activation of P58 IPK (Katze et al., 1988; Lee and Katze, 1994) . The released P58 IPK is then capable of interacting with PKR by binding to amino acids 244-296, which prevents dimerization and activation of PKR (Tan et al., 1998) . Our results also show that M2 proteins could bind to P58 IPK and be able to promote PKR autophosphorylation and activation in vitro and in vivo. Therefore, it is probable that M2 proteins form a stable complex with Hsp40-P58 IPK and hinder the disassociation of Hsp40-P58
IPK
. As M2 is synthesized in the late stage of virus infection (Odagiri et al., 1999) , together with the early-synthesized NS1 to inactivate the PKR activity (Bergmann et al., 2000) , influenza virus regulates/ interferes cell functions to facilitate its replication through its protein products (NS1 and M2) interacting with PKR-related proteins.
RESULTS

Identification of a BM2-interacting protein in the yeast two-hybrid system
Since influenza virus is able to infect several tissues in human beings, such as lung, liver, brain etc, a prey library of human kidney cDNA was used in a yeast two-hybrid screen to identify proteins that interact with BM2, with the portion of the cytoplasmic domain of BM2 (BM2C) as bait. One positive clone containing cDNA with entire open reading frame encoding Hsp40/Hdj1 was isolated from a library of approximately 1 × 10 6 independent clones. To confirm the observed interaction between BM2 and Hsp40 in the yeast, we set up a growth experiment on SD plate lacking adenine, tryptophan, leucine and histidine in the two hybrid system. In this assay, growth on SD medium is supported only when the two hybrid proteins interact and induce transcription from the his reporter gene. We found that two yeast clones co-expressing ADHsp40/BD-BM2 and AD-p53/BD-T antigen (positive control) constructs grew on this medium (Fig. 1A) . We also carried out liquid β-galactosidase assays by co-transforming the recombinant plasmids to yeast strain SFY526. As shown in Fig. 1B , co-transformation of AD-Hsp40 and BD-BM2C resulted in a strong induction of β-galactosidase activity, significantly higher than that of the respective control co-transformations. These results collectively indicate that BM2 and Hsp40 interact with each other.
Interaction between BM2 and Hsp40 in vitro and in vivo
To verify and extend the binding data obtained in yeast twohybrid assay, we performed GST pull-down experiments. Bacterially expressed GST-BM2C or GST bound to glutathione-Sepharose beads was allowed to react with in vitro translated [ 35 S]methionine-labeled Hsp40 in reaction buffer.
Consistent with the yeast two-hybrid results, Hsp40 specifically bound to GST-BM2C, but not GST ( Fig. 2A) .
To further assess the interaction between BM2 and Hsp40 in vivo, the plasmids that express Flag-Hsp40 or GFP-BM2 were co-transfected into 293T cells. The cell lysates were then immunoprecipitated with the anti-Flag M2-conjugated agarose and subsequently immunobloted with anti-GFP antibody. Consistent with the GST pull-down and yeast twohybrid results, BM2 specifically interacted with Hsp40 (Fig.  2B) . A reciprocal co-immunoprecipitation experiment also showed the physical interaction between BM2 and Hsp40 (Fig. 2C) .
Mapping the BM2 binding domain of Hsp40
To determine the region of Hsp40 that is responsible for its interaction with BM2, a series of Hsp40 deletion mutants were constructed to test for their ability to interact with BM2 in GST pull-down assays (Fig. 3A) . Full-length Hsp40 and its deletion mutants were translated, [
35 S]-methionine labeled in vitro, and then incubated with GST-BM2C or GST alone. As shown in Fig. 3B , full-length Hsp40, Hsp40 (1-246 aa) including J Protein & Cell were grown on an SD plate lacking adenine, tryptophan, leucine and histidine. Growth of the yeast on this plate is indication of interaction of the two expressed proteins. BD, pGBKT7 vector expressing GAL4 DNA binding domain; BD-x (e.g., BD-BM2C), the in-frame cloned plasmid of the relevant gene in pGBKT7 (pGBKT7-BM2C). AD, pACT2 vector expressing the transcription activation domain; AD-x (e.g., AD-Hsp40), the in-frame cloned plasmid of the relevant gene in pACT2 (pACT2-Hsp40). BD-T antigen, BD-LaminC and ADp53 are control vectors supplied by Clontech. Interaction of BD-T antigen with AD-p53 is used as a positive control whereas BD-LaminC and AD-p53 is used as a negative control. (B) Quantification of β-galactosidase activity. Data shown are the means of three separate experiments and error bars are standard deviations. Co-transfection pair plasmid combinations are as follows: 1, pACT2-Hsp40 and pGBKT7-BM2C; 2, pACT2-Hsp40 and pGBKT7; 3, pACT2-Hsp40 and pAS2-LaminC; 4, pACT2 and pGBKT7; 5, pACT2 and pGBKT7-BM2C; 6, pGBKT7-T antigen and pACT2-p53 (positive control); 7, pGBKT7-LaminC and pACT2-p53 (negative control).
domain, G/F domain and CTD1, Hsp40 (162-340 aa) including CTD1, CTD2 and DD, and Hsp40 (162-246 aa) only including CTD1 were able to interact with BM2, but not Hsp40 (1-162 aa) including J domain and G/F domain. As negative control, the full-length and deletion mutants of Hsp40 did not bind to GST alone. These results indicated that Hsp40 interacted with BM2 through its CTD1.
Interaction between A/M2 and Hsp40 in vitro and in vivo
A/M2 protein of influenza A virus is structurally and biochemically similar to BM2, so we examined the possibility of A/M2 binding to Hsp40 in GST pull-down and co-IP assays. Purified GST and GST-Hsp40 immobilized on glutathioneSepharose beads were used to pull down in vitro translated and [
35 S]-methionine labeled A/M2. The results indicated that Hsp40 also specifically bound to A/M2 in vitro, but not GST ( Enhancement of PKR autophosphorylation in vitro and in vivo by M2 proteins P58 IPK is a negative regulator of PKR, the repression of its activity may result in increase in autophosphorylation of PKR and subsequent enhancement of phosphorylation of the α subunit of eukaryotic initiation factor 2 (eIF2α). Therefore, to examine the functional consequences of the interaction described above, we first performed an in vitro kinase assay using purified Flag-PKR immobilized onto anti-Flag M2-conjugated agarose in the presence of GST-P58 IPK alone or both GST-BM2C and GST-P58 IPK as described under "Materials and Methods." As shown in Fig. 7A , the autophosphorylation of PKR was blocked by P58 IPK in vitro, and then was reversed by BM2 protein when its activator dsRNA was added.
To determine whether M2 protein has an effect on PKR autophosphorylation in mammalian cells, 293T cells were cotransfected with expression vectors for Flag-P58 IPK and
Flag-A/M2 or Flag-BM2 constructs at 1:1 ratio and treated with IFN-α and poly(I:C) as described in "Materials and Methods." As a control, cells were transfected with empty vector alone. Cell extracts were then prepared and analyzed by SDS-PAGE and Western blotting with phospho-PKR antibody. As shown in Fig. 7B , overexpression of BM2 or A/ M2 in 293T cells increased the autophosphorylation of PRK due to the inhibition of P58 IPK activity via forming a complex with M2 protein.
Induction of death in HeLa cells with M2 proteins
To examine whether death was initiated in the cells transfected with pCAGGS-AM2/BM2, PI staining and flow cytometry were used to analyze the percentages of death in the total cell population. Dead cells have a weaker fluorescence (M1 zone) (Fig. 8A) . Ratio of M1 and M1 + M2 represents the percentages of dead cells (Fig. 8B) . The results showed that HeLa cells transfected with pCAGGS-AM2/BM2, exhibited cell death in a time-dependent manner (Fig. 8) . The maximal cell death occurred at 72 h posttransfection, the dead cells increased to 13.04% and 15.78% respectively, in cells transfected with pCAGGS-AM2/BM2 In contrast, only 5.75% dead cells were observed in cells transfected with an empty vector.
DISCUSSION
Hsp40 family is involved in numerous cellular functions, including regulation of protein folding, translocation and assembly by cooperating with Hsp70 (Cheetham and Caplan, 1998; Ohtsuka and Hata, 2000) . However, it has been recently reported that Hsp40 interacts with HBV core protein and inhibits viral replication (Sohn et al., 2006) . Here we report for the first time that BM2 interacts with Hsp40, which has been identified by yeast two-hybrid screening and further confirmed by GST pull-down and immunoprecipitation experiments. Hsp40/Hdj1 belongs to the Type II Hsp40s, containing a J-domain, a G/F-rich domain, two conserved carboxylterminal domains (CTD1 and CTD2) and a predicted dimerization domain (Mohler et al., 2004 ]-methionine was added to incubation buffer for 3 h. After washing, the protein complexes were dissociated from the beads and subjected to SDS-PAGE followed by autoradiography. interferon-mediated cellular antiviral and antiproliferative responses (Gale et al., 1996) . By binding to dsRNA, PKR undergoes a conformational change and becomes autophosphorylated at multiple serine and threonine sites, and the activated PKR then phosphorylates specific substrate eIF2α at Ser51, leading to an inhibition in protein synthesis and a block in viral replication (Meurs et al., 1992; Srivastava et al., 1998) . Many viruses have evolved elaborate mechanisms to evade the host defense, such as production of multifunctional proteins binding to dsRNA or direct interaction with PKR . Influenza A virus has developed two strategies to block the activation of PKR. First, it encodes a non-structural protein (NS1) that can bind to dsRNA to prevent PKR autophosphorylation (Lu et al., 1995) (Morris et al., 2002) . It is reported that A/M2 is highly toxic for mammalian cells, yeast and insect cells (Ilyinskii et al., 2007 (Ilyinskii et al., , 2008 associating with host partners Hsp40 and P58 IPK leads to the autophosphorylation of PKR, reduction of host proteins synthesis, and finally, induction of cell apoptosis.
It has been thought that the induction of apoptosis is a host defense response, stopping the replication and spread of virus. However, the increasing evidence has shown that apoptosis induction is beneficial for influenza virus replication. First of all, the expression of anti-apoptosis protein Bcl-2 which inhibits influenza virus-induced apoptosis reduces virus replication, spread and HA glycosylation (Olsen et al., 1996) . Furthermore, the inhibition of caspase 3 activity which is a member of the central component of the apoptotic machinery strongly impairs influenza virus propagation (Wurzer et al., 2003) . It seems that influenza virus has acquired the capability to take advantage of the protection machinery of the host cells, thereby supporting viral replication. The virus probably needs some mechanisms to keep the balance between limitation of antiviral response and maintenance of sufficient signaling strength to support virus growth. Such a balance may be controlled by proteins encoded by influenza virus. There are several proteins of influenza virus that has been reported to act as apoptosis promoters: NS1, PB1-F2, NA and M2. But the data that NS1 acts as apoptosis inducer (Schultz-Cherry et al., 2001 ) was challenged by the finding that recombinant influenza virus lacking NS1 still induced cell apoptosis. It is expressed during the early stage of infection and has been described as an inhibitor of PKR to promote viral protein synthesis. NA was the first influenza virus protein shown to have a role in the induction of apoptosis (Schultz-Cherry and Hinshaw, 1996; Morris et al., 1999) . It can activate TGF-β at the cell surface by facilitating cleavage of TGF-β into its active form. However, NA is not the sole contributor to apoptosis as UV-irradiated virus, which retains 100% NA activity, weakly induced apoptosis. PB1-F2 is known to localize in the mitochondria of the infected cell and to sensitize cells to death through interactions with two mitochondrial proteins, ANT3 and VDAC1 (Zamarin et al., 2005) . These interactions promote the permeabilization of the mitochondria, facilitate the release of mitochondrial products and trigger cell apoptosis. Like PB1-F2, M2 protein is expressed during the later stages of the infection cycle. This correlates well with late requirement for TRAIL and caspase activity in the viral replication cycle. Their pro-apoptotic effect most likely is not inhibitory to viral replication.
Based on our results, we propose the following model for the regulation of PKR pathway by influenza virus proteins during the infection (Fig. 9) . PKR remains latent in unstimulated cells, and its activation requires binding of specific activators. P58
IPK is also inactive before influenza virus infection because it is bound to Hsp40. Early in the infection, PKR is activated by dsRNA generated by viruses. Moreover, NS1 is expressed and blocks the dsRNA-mediated activation of PKR to fight against host defense and support normal viral replication. P58 IPK is also activated to block the dimerization and activation of PKR due to the disruption of Hsp40-P58 
METHODS
Plasmid construction
To generate GST or Flag epitope-tagged full-length protein of Hsp40, PCR was performed to amplify Hsp40 DNA fragment from the original yeast two-hybrid library clone (pACT2-Hsp40) (see below). The PCR product was digested with BamH I-Xho I and then inserted into pGEX6p-1 and pcDNA3-Flag (Clontech). Deletion mutants of Hsp40 were constructed by inserting PCR-generated fragments from the corresponding cDNAs into the pcDNA3-Flag vector. The mammalian expression plasmids of wild-type BM2 and A/M2 fused with Flag epitope were generated by constructing to pCAGGS/ MCS vector (kindly provided by Dr Y. Kawaoka, The University of Tokyo). The plasmid pcDNA3-Flag-PKR was constructed to use for purification of PKR protein by amplifying a full-length PKR cDNA from a human kidney cDNA library (Clontech) and then inserting to pcDNA3-Flag vector. For the expression of P58 IPK in mammalian cells and E. coli, a P58 IPK cDNA was obtained from Hela cells by RT-PCR and inserted to pcDNA3-Flag and pGEX6p-1 vector, respectively. The PCR fragment product (BM2C) of cytoplas- 
Yeast two-hybrid screening
For the initial screening, pGBKT7-BM2C was used as bait and pACT cDNA library (Clontech) from human kidney was used as a source of prey genes. The bait pGBKT7-BM2C plasmid and the pACT2 cDNA library were transformed into the yeast strain AH109 by lithium acetate method (yeast protocols handbook, Clontech). Transformants were plated onto SD medium lacking tryptophan, leucine and histidine but containing 1 mM 3-aminotriazole. The candidate clones were rescued from the yeast cells and introduced to the yeast strain SFY526 to verify the interaction by detecting β-galactosidase activity. For quantitative β-galactosidase assays, colonies were grown to mid-logarithmic phase in liquid selection medium before cells were harvested and lysed by the glass-bead method (yeast protocols handbook, Clontech). The procedures for library amplification, yeast cell transformation, screening for growth in the absence of histidine, and measurement of β-galactosidase activity followed the Matchmaker protocol (Clontech).
Cell lines and reagents
293T and Hela cells were cultured in high-glucose DMEM (Gibco) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, and penicillin-streptomycin (100 units/mL; Invitrogen). Anti-Flag monoclonal M2 antibody, M2 anti-Flag-agarose, and poly(I:C) (synthetic dsRNA) were purchased from Sigma. The polyclonal anti-PKR antibody (N-18; sc-6282) and phospho-specific anti-PKR antibody (against phosphorylated threonine 446) were purchased from Santa Cruz Biotechnology.
Cell lysis and immunoblotting experiments
To analyze whether M2 protein affects PKR autophosphorylation in vivo, we performed the following assays. 293T cells were transfected with Flag-tagged A/M2, BM2 and/or P58 IPK constructs. Twenty-four hours later, the cells were treated with alpha interferon (IFN-α) at 1000 U/mL for 24 h, and then poly (I:C) (100 μg/mL) was added directly to the cell culture medium for 6 h to activate PKR. To harvest, the cells were washed once with PBS buffer and proteins were extracted in ice-cold lysis buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.5% NP-40, 1 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF), CPI cocktail (Boehringer Mannheim) as the source of protease inhibitors. The
Protein & Cell extracts were clarified by microcentrifugation at 13,000 rpm for 10 min. The protein concentration was determined by bicinchoninic acid (BCA) protein assay kit (Pierce Biotechnology), and 40 μg of protein were fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The proteins were then electroblotted onto PVDF membrane, which was incubated with each of the following antibodies: phosphorylation site-specific antibody to PKR (Thr446), rabbit polyclonal antibodies to PKR and to β-actin as a control for protein loading. The secondary antibodies were horseradish peroxidase-conjugated anti-rabbit or antigoat IgG (Amersham Biosciences) used at a dilution of 1:5000 in blocking solution.
Co-immunoprecipitation (Co-IP) assay
Immunoprecipitation assays were performed essentially as described previously (Yan et al., 2003; Fan et al., 2006) . Briefly, 293T cells were transiently transfected with the indicated plasmids using Lipofectamine 2000 reagents (Invitrogen). After 48 h of cultivation, the cells were washed and resuspended in 0.5 mL lysis buffer (mentioned above). Equal amounts of cleared cell lysates were subjected to immunoprecipitate with anti-Flag monoclonal antibody M2-conjugated agarose. The reactions were performed overnight at 4°C, and then the beads were centrifuged at 3000 rpm for 2 min and washed three times with lysis buffer. The antibodyprotein complexes were then resolved by SDS-PAGE, and the GFP or Flag-tagged proteins were identified by Western blotting with an anti-GFP/Flag antibody probe using an enhanced chemiluminescence system. For the detection of interaction between P58 IPK and A/M2 in the virus-infected cells, 293T cells were transfected with pFlag-P58 IPK plasmid for 24 h, and then infected by influenza virus A/WSN/33. After 24 h, co-immunoprecipitation was performed with anti-A/M2 antibody (Abcam), non-immunized mouse IgG as a negative control.
Preparations of GST fusion proteins and GST pull-down assay
The interactions between M2 and Hsp40 or P58 IPK in vitro were examined by GST pull-down assays. Transformants of E. coli BL21 bearing plasmids encoding GST or different GST fusion proteins were grown to an optical density at 600 nm (OD 600 ) of 0.6-0.7, and IPTG was added to 0.1 mM to induce expression of the GST proteins for 12 h at 16°C. Total proteins were extracted by sonicating cells in PBS buffer containing NP-40 and protein inhibitors, followed by centrifugation at 12,000 × g for 15 min at 4°C. The supernatant were purified by glutathione-Sepharose 4B beads according to the manufacturer's recommended protocol (Amersham Pharmacia Biotech Amersham) and the TNT T7 coupled reticulocyte lysate system (Promega) were used as instructed by the manufacturer. GST binding assays were conducted as follows: The 35 S-labeled proteins were incubated with 10 μg of GST derivatives bound to glutathione-Sepharose beads in 0.5 mL binding buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1mM DTT, 1 mM PMSF and protease inhibitors). The binding reaction was performed at 4°C overnight and the beads were subsequently washed four times with the binding buffer. The beads were then resuspended in 10 μL of 2 × SDS sample buffer, resolved by SDS-PAGE and followed by autoradiography.
Protein kinase assay
Purified recombinant Flag-tagged PKR immunoprecipitated from cell extracts were used for the in vitro kinase reactions in kinase reaction buffer containing 20 mM HEPES, pH 7.4, 1mM DTT, 5 mM MgCl 2 , 20 μM ATP, 5 μCi of [γ-32 P]ATP (6mCi/mmol). Whenever indicated, poly(I:C) was added to a final concentration of 1 μg/mL. The kinase reactions were incubated for 30 min at 30°C, stopped by the addition of 2 × SDS-PAGE sample buffer, boiled for 5 min, and analyzed by SDS-PAGE (10%). The degree of PKR phosphorylation was visualized by autoradiography.
Cell death assay
HeLa cells were cultured in 6-well plates and allowed to grow to 75%-80% confluency, and then were transfected with pCAGGS-AM2/BM2 (3 μg/well). Cells were collected at 24, 48 and 72 h post-transfection, washed twice with PBS and fixed by 75% cooling ethanol overnight. The fixed cells were then stained with 50 μg/mL PI in the dark at room temperature for 15 min. A minimum of 1 × 10 5 cells for each group was analyzed by fluorescence activated cell sorting (FACS).
